Activities of Rolandas PAKSAS related to 2017/2254(INI)
Shadow opinions (1)
OPINION on a European One Health Action Plan against Antimicrobial Resistance (AMR)
Amendments (5)
Amendment 30 #
Draft opinion
Paragraph 1
Paragraph 1
1. Emphasises the need to encourage the use of metagenomics methods and to increase funding for R&I in epidemiology and immunology for AMR pathogens and healthcare-associated infections (HAI);
Amendment 34 #
Draft opinion
Paragraph 1 a (new)
Paragraph 1 a (new)
1a. Stresses the need to provide investment and market incentives to promote research and development, to deliver new antimicrobials, vaccines, rapid diagnostics and alternative antimicrobial therapies;
Amendment 62 #
Draft opinion
Paragraph 3
Paragraph 3
3. Expresses the urgent need to build a more holistic system for monitoring AMR issues, linking data on resistance, consumption and sales of antimicrobials to prescribing trends and other factors and to foster partnerships throughout the EU in order to enhance the exchange of best practices and improve knowledge on AMR;
Amendment 63 #
Draft opinion
Paragraph 3
Paragraph 3
3. Expresses the urgent need to foster partnerships throughout the EU in order to enhance the exchange of best practices and improve knowledge on AMR; points out that particular attention must be paid to strengthening cooperation with the biotechnology research and industry sectors;
Amendment 71 #
Draft opinion
Paragraph 4
Paragraph 4
4. SCalls for strengthening global surveillance of AMR and antimicrobial usage in humans, animals and the environment to better understand the problem and inform actions; stresses the need to improve data collection on a systemic level throughout the EU, and to monitor and act rapidly on AMR-related trends and developments; points out the added value of eHealth and digitalisation, which offer the opportunity to pool and cumulate data on AMR;